SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-052284
Filing Date
2018-08-15
Accepted
2018-08-15 16:26:42
Documents
1
Period of Report
2018-08-13

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4072
  Complete submission text file 0001104659-18-052284.txt   5513
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BIND THERAPEUTICS, INC. 325 VASSAR STREET CAMBRIDGE MA 02139
Business Address
YINGLING JONATHAN MICHAEL (Reporting) CIK: 0001660011 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 181021298